Hims & Hers Health's planned 2026 Canadian expansion represents a pivotal strategic shift, combining its recent acquisition of European digital health platform ZAVA with the anticipated launch of...
The pharmaceutical industry witnessed a landmark transaction on July 9, 2025, as Merck & Co. announced its definitive agreement to acquire Verona Pharma for approximately $10 billion, securing...
In a landmark transaction reshaping India's pharmaceutical landscape, Torrent Pharmaceuticals announced the acquisition of KKR's 46.39% controlling stake in JB Chemicals & Pharmaceuticals for...
Danone has significantly advanced its gut health research capabilities through the acquisition of The Akkermansia Company, a pioneer in next-generation probiotics and postbiotics. This strategic...
ProAssurance Corporation (NYSE: PRA) shareholders have delivered a decisive mandate for the company's acquisition by The Doctors Company, with over 99% of voting shares endorsing the $1.3 billion...
The $3.3 billion standoff between Surgery Partners and Bain Capital represents a defining moment in healthcare private equity, revealing fundamental tensions between short-term liquidity events and...
Eli Lilly's acquisition of Verve Therapeutics for up to $1.3 billion marks a watershed moment in the convergence of gene editing and cardiovascular therapeutics. This deal, announced on June 17,...
The Pennsylvania House of Representatives has passed landmark legislation (House Bill 1460) imposing unprecedented oversight on private-equity healthcare transactions, marking a watershed moment in...
In a landmark consolidation of Germany's biotechnology sector, BioNTech SE (NASDAQ: BNTX) has announced its acquisition of CureVac NV (NASDAQ: CVAC) through an all-stock transaction valued at $1.25...
Private equity giant Advent International has positioned itself at the forefront of the emerging animal health generics market through a $175 million strategic investment in Ireland-based Felix...
